Valuation: Healius Limited

Market Cap 265M 186M 161M 150M 138M 260M 17.74B 1.77B 695M 8.81B 698M 682M 29.62B P/E 2026 *
-9.61x
P/E 2027 * -102x
Enterprise Value 1.17B 822M 714M 663M 612M 1.15B 78.48B 7.85B 3.07B 38.98B 3.09B 3.02B 131B EV / Sales 2026 *
0.85x
EV / Sales 2027 * 0.84x
Free-Float
77.51%
Yield 2026 *
-
Yield 2027 * 0.36%
1 day+2.74%
1 week+7.14%
Current month-3.85%
1 month-3.85%
3 months-25.74%
6 months-58.33%
Current year-58.56%
1 week 0.34
Extreme 0.34
0.38
1 month 0.34
Extreme 0.34
0.4
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
3.05
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 2024-03-04
Director of Finance/CFO - 2025-10-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2018-08-20
Chairman 65 2023-11-27
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
11/19/25 Buy

Chief Executive Officer

54,431 0.0075%
11/10/25 Free

Director

45,955 0.0063%
11/3/25 Buy

Chief Executive Officer

57,471 0.0079%
Change 5-day change 1-year change 3-year change Capi.($)
+2.74%+7.14%-51.30%-86.93% 186M
+6.24%+1.88%+91.30%+487.75% 38.62B
+2.73%+8.42%+19.56%+47.00% 25.53B
-2.84%+5.10%-21.08%-37.81% 7.79B
-1.07%+2.80%+10.58%+93.07% 4.93B
+1.13%+12.57%+22.56%+63.28% 3.29B
+3.99%+11.52%+211.37%-8.00% 2.04B
+8.28%+8.80%-33.38%+865.83% 2.05B
-1.02%+0.11%-12.56%-62.32% 1.86B
+0.83%+2.35%+16.71%+5.34% 1.82B
Average +2.10%+3.31%+25.38%+136.72% 8.81B
Weighted average by Cap. +3.54%+2.26%+49.35%+250.18%

Financials

2026 *2027 *
Net sales 1.38B 966M 839M 779M 719M 1.35B 92.24B 9.23B 3.61B 45.81B 3.63B 3.55B 154B 1.42B 995M 865M 803M 740M 1.39B 95.03B 9.51B 3.72B 47.2B 3.74B 3.66B 159B
Net income -27.45M -19.24M -16.71M -15.52M -14.31M -26.96M -1.84B -184M -71.93M -912M -72.25M -70.67M -3.07B -447K -314K -272K -253K -233K -439K -29.94M -3M -1.17M -14.87M -1.18M -1.15M -50.01M
Net Debt 908M 636M 553M 513M 473M 892M 60.75B 6.08B 2.38B 30.17B 2.39B 2.34B 101B 930M 652M 566M 526M 485M 913M 62.22B 6.22B 2.44B 30.9B 2.45B 2.39B 104B
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
5,962
Date Price Change Volume
26-07-31 A$0.3750 +2.74% 4,375,291
26-07-30 A$0.3650 -2.67% 1,505,190
26-07-29 A$0.3750 +7.14% 3,210,050
26-07-28 A$0.3500 +1.45% 1,060,298
26-07-27 A$0.3450 -1.43% 2,088,564
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
0.3650AUD
Average target price
0.4962AUD
Spread / Average Target
+35.94%

Quarterly revenue - Rate of surprise